Portal de Periódicos da CAPES

Favorable Outcomes of Liver Transplantation from Controlled Circulatory Death Donors Using Normothermic Regional Perfusion Compared to Brain Death Donors

2020; Wolters Kluwer; Volume: 104; Issue: 9 Linguagem: Inglês

10.1097/tp.0000000000003372

1534-6080

Eric Savier, Chétana Lim, Michel Rayar, Francesco Orlando, Karim Boudjéma, Kayvan Mohkam, Mickaël Lesurtel, Jean Yves Mabrut, Gabriella Pittau, Nassiba Begdadi, Daniel Cherqui, René Adam, Fédérica Dondero, Ailton Sepulveda, Olivier Soubrane, Petru Bucur, Louise Barbier, Éphrem Salame, Carine Jasseron, Corinne Antoine, Bruno Riou, Olivier Scatton,

Organ Donation and Transplantation

Background. Liver transplantation (LT) from controlled donation after circulatory death (cDCD) was initiated in France in 2015 under a protocol based on the use of normothermic regional perfusion (NRP) before organ procurement. The aim was to compare outcomes following cDCD LT with NRP and donation after brain death (DBD) LT. Methods. This is a multicenter retrospective study comparing cDCD LT with NRP and DBD LT. A case-matched study (1:2) was performed using the variables such as recipient and donor age, indication of LT. Results. A total of 50 patients from the cDCD group were matched to 100 patients from the DBD group. From postoperative days 1–4, serum transaminase release was significantly lower in the cDCD group compared to the DBD group ( P < 0.05). Early allograft dysfunction (cDCD: 18% versus DBD: 32%; P = 0.11), acute kidney injury (26% versus 33%; P = 0.49), 90-d graft loss (2% versus 5%; P = 0.66), and arterial (4% versus 12%; P = 0.19) and biliary (16% versus 17%; P = 0.94) complications were similar between the 2 groups. The 2-y graft survival was 88% for cDCD group and 85% for DBD group ( P = 0.91). The 2-y patient survival was 90% for cDCD group and 88% for DBD group ( P = 0.68). Conclusions. This study provides evidence that cDCD LT following postmortem NRP can be safely and effectively performed in selected recipients with similar graft and patient survival outcomes, without increased rates of biliary complications and early graft dysfunction compared to DBD LT.